Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 29:14:1-5.
doi: 10.1016/j.phro.2020.04.001. eCollection 2020 Apr.

Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases

Sweet Ping Ng  1   2 , Carlos E Cardenas  3 , Hesham Elhalawani  1 , Courtney Pollard 3rd  1 , Baher Elgohari  1 , Penny Fang  1 , Mohamed Meheissen  4 , Nandita Guha-Thakurta  5 , Houda Bahig  6 , Jason M Johnson  5 , Mona Kamal  1 , Adam S Garden  1 , Jay P Reddy  1 , Shirley Y Su  7 , Renata Ferrarotto  8 , Steven J Frank  1 , G Brandon Gunn  1 , Amy C Moreno  1 , David I Rosenthal  1 , Clifton D Fuller  1 , Jack Phan  1
Affiliations

Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases

Sweet Ping Ng et al. Phys Imaging Radiat Oncol. .

Abstract

In treatment planning, multiple imaging modalities can be employed to improve the accuracy of tumor delineation but this can be costly. This study aimed to compare the interobserver consistency of using dual energy computed tomography (DECT) versus magnetic resonance imaging (MRI) for delineating tumors in the head and neck cancer (HNC) re-irradiation scenario. Twenty-three patients with recurrent HNC and had planning DECT and MRI were identified. Contoured tumor volumes by seven radiation oncologists were compared. Overall, T1c MRI performed the best with median DSC of 0.58 (0-0.91) for T1c. T1c MRI provided higher interobserver agreement for skull base sites and 60 kV DECT provided higher interobserver agreement for non-skull base sites.

Keywords: Delineation; Dual energy computed tomography; Head and neck; Magnetic resonance imaging; Re-irradiation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Pairwise analysis for the cohort (A–E) and stratified by skull base versus non-skull base tumor sites (F – J): A and F) Dice similarity coefficient (DSC), B and G) volume difference, C and H) mean surface distance (MSD), D and I) Hausdorff distance (HD) and E and J) 95th percentile Hausdorff distance (95HD).
Fig. 2
Fig. 2
Example of a skull base (A) and a non-skull base (B) cases with delineations on 60 kV, 140 kV, T1 with contrast (T1 + c) and T2 MRI sequences.
See this image and copyright information in PMC

References

    1. Mabanta S.R., Mendenhall W.M., Stringer S.P., Cassisi N.J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591–594. - PubMed
    1. Ng S.P., Phan J. Stereotactic radiotherapy and proton therapy for locally recurrent head and neck cancer. Austin Head Neck Oncol. 2017;1:1002.
    1. De Crevoisier R., Bourhis J., Domenge C., Wibault P., Koscielny S., Lusinchi A. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998;16:3556–3562. - PubMed
    1. Langer C.J., Harris J., Horwitz E.M., Nicolaou N., Kies M., Curran W. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007;25:4800–4805. - PubMed
    1. Spencer S.A., Harris J., Wheeler R.H., Machtay M., Schultz C., Spanos W. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck. 2008;30:281–288. - PubMed

LinkOut - more resources